This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Peverill, R. E. Articles by Smolich, J. J. Search for Related Content PubMed PubMed Citation Articles by Peverill, R. E. Articles by Smolich, J. J.

(Circulation. 1996;94:331-339.)
© 1996 American Heart Association, Inc.

Articles

Determinants of Increased Regional Left Atrial Coagulation Activity in Patients With Mitral Stenosis

Roger E. Peverill, MBBS; Richard W. Harper, MBBS; John Gelman, MBBS; T. Eng Gan, MBBS; Geoff Harris, BAppSc; Joseph J. Smolich, MBBS, PhD

the Cardiology Unit (R.E.P., R.W.H., J.G., J.J.S.), Hematology Unit (T.E.G., G.H.), and Institute of Reproduction and Development (J.J.S.), Monash Medical Centre, Melbourne, Australia.

Correspondence to Dr J.J. Smolich, Cardiology Unit, Monash Medical Centre, 246 Clayton Rd, Clayton, Victoria, 3168, Australia. E-mail joe.smolich@med.monash.edu.au.

Background Recent evidence suggests that regional left atrial coagulation activity may be increased in mitral stenosis and perhaps contribute to the pathophysiology of left atrial thrombus. However, the relation of left atrial coagulation activity to factors that predispose to left atrial thrombus formation is unknown, and the relation between left atrial and systemic coagulation activities is unresolved.

Methods and Results Left atrial and peripheral venous levels of the coagulation marker prothrombin fragment 1+2 (F1+2) were measured in 32 patients with mitral stenosis with normal clotting times and no left atrial thrombus who were undergoing percutaneous balloon mitral valvuloplasty. Baseline peripheral venous F1+2 levels, measured at the beginning of the valvuloplasty procedure, did not differ from those of 30 age-matched control patients. Prevalvuloplasty left atrial F1+2 levels, obtained immediately after transseptal puncture, were similar to femoral venous levels in patients without left atrial spontaneous echo contrast (LASEC) (0.81±0.32 versus 0.81±0.27 nmol/L, n=7) but greater than femoral venous levels in patients with LASEC and either sinus rhythm (1.57±0.86 versus 0.99±0.38 nmol/L, n=16, P<.001) or atrial fibrillation (1.52±0.69 versus 0.85±0.33 nmol/L, n=9, P<.003). Furthermore, LASEC emerged as the only significant predictor of increased regional left atrial coagulation activity (P=.005) on stepwise multivariate logistic regression analysis.

Conclusions Increased regional left atrial coagulation activity in mitral stenosis occurs in the presence of LASEC, is evident in either sinus rhythm or atrial fibrillation, and is associated with normal systemic coagulation activity.

Key Words: atrium • coagulation • echocardiography • mitral valve

This article has been cited by other articles:

				M. Nobuyoshi, T. Arita, S.-i. Shirai, N. Hamasaki, H. Yokoi, M. Iwabuchi, H. Yasumoto, and H. Nosaka Percutaneous Balloon Mitral Valvuloplasty: A Review Circulation, March 3, 2009; 119(8): e211 - e219. [Full Text] [PDF]

				Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 651 - 745. [Full Text] [PDF]

				V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246. [Full Text] [PDF]

				V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): e257 - e354. [Full Text] [PDF]

				R. Atak, E. Yetkin, O. Yetkin, S. Ayaz, M. Ileri, K. Senen, H. Turhan, A. R. Erbay, and S. Cehreli Increased Systemic and Regional Coagulation Activity in Patients with Mitral Stenosis and Sinus Rhythm Angiology, September 1, 2003; 54(5): 593 - 597. [Abstract] [PDF]

				S. Kamath, A.D. Blann, and G.Y.H. Lip Platelets and atrial fibrillation Eur. Heart J., December 2, 2001; 22(24): 2233 - 2242. [PDF]

				O. Yamamura, Y. Miyoshi, S. Hiraki, H. Ono, H. Ootaki, J. Fujiyama, and M. Kuriyama Spontaneous Echo Contrast in Descending Aorta Correlates with Low Blood-Flow Velocity in Carotid Arteries and Hemostatic Abnormalities Angiology, November 1, 2001; 52(11): 749 - 758. [Abstract] [PDF]

				Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology Eur. Heart J., October 2, 2001; 22(20): 1852 - 1923. [PDF]

				V. Fuster, L. E. Ryden, R. W. Asinger, D. S. Cannom, H. J. Crijns, R. L. Frye, J. L. Halperin, G. N. Kay, W. W. Klein, S. Levy, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1266 - 1266. [Full Text] [PDF]

				M. Jahangiri, J. Kreutzer, D. Zurakowski, E. Bacha, and R. A. Jonas Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 778 - 782. [Abstract] [Full Text] [PDF]

				I. Hisar, M. Ileri, E. Yetkin, R. Atak, K. Senen, F. Kosar, S. Dundar, and D. Demirkan Role of Activated Protein C Resistance in Left Atrial Thrombogenesis in Patients with Mitral Stenosis Angiology, October 1, 2000; 51(10): 855 - 860. [Abstract] [PDF]